other material
confidence high
sentiment negative
materiality 0.85
Adagio Medical Holdings, Inc. (ADGM): auditor change — Adagio Medical announces restatement of FY2023, Q1 and Q2 2024 financials; material weakness identified
Adagio Medical Holdings, Inc.
- Audit committee concluded FY2023 audited and Q1/Q2 2024 unaudited statements should not be relied upon due to accrued interest misstatement.
- Error found during Q3 2024 prep; overstatement of accrued interest on convertible notes and other liabilities.
- Company will restate financials via Amendment No. 2 to the Business Combination Super 8-K.
- Material weakness in internal control over financial reporting regarding review of third-party valuation reports for debt/equity.
- Remediation plan includes additional review of valuation reports, manual journal entries, and enhanced oversight controls.